These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 25301948)
1. Crystal structure of the human fatty acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibition. Sippel KH; Vyas NK; Zhang W; Sankaran B; Quiocho FA J Biol Chem; 2014 Nov; 289(48):33287-95. PubMed ID: 25301948 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers. Khade AB; Kar SS; Alummoottil CT; Tiwari A; Tiwari M; Eshwara VK; Bhat P; Giliyar VB; Shenoy GG Med Chem; 2020; 16(2):256-270. PubMed ID: 30848207 [TBL] [Abstract][Full Text] [Related]
3. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of triclosan resistance. Singh NJ; Shin D; Lee HM; Kim HT; Chang HJ; Cho JM; Kim KS; Ro S J Struct Biol; 2011 Apr; 174(1):173-9. PubMed ID: 21094257 [TBL] [Abstract][Full Text] [Related]
5. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum. Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275 [TBL] [Abstract][Full Text] [Related]
6. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan. Mehboob S; Truong K; Santarsiero BD; Johnson ME Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289 [TBL] [Abstract][Full Text] [Related]
7. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822 [TBL] [Abstract][Full Text] [Related]
8. Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity. Lu H; England K; am Ende C; Truglio JJ; Luckner S; Reddy BG; Marlenee NL; Knudson SE; Knudson DL; Bowen RA; Kisker C; Slayden RA; Tonge PJ ACS Chem Biol; 2009 Mar; 4(3):221-31. PubMed ID: 19206187 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and Structural Basis of Triclosan Resistance in a Novel Enoyl-Acyl Carrier Protein Reductase. Khan R; Zeb A; Roy N; Thapa Magar R; Kim HJ; Lee KW; Lee SW Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891603 [TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa. Lee JH; Park AK; Chi YM; Moon JH; Lee KS Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088 [TBL] [Abstract][Full Text] [Related]
12. Structural basis for the variation in triclosan affinity to enoyl reductases. Pidugu LS; Kapoor M; Surolia N; Surolia A; Suguna K J Mol Biol; 2004 Oct; 343(1):147-55. PubMed ID: 15381426 [TBL] [Abstract][Full Text] [Related]
13. A triclosan-resistance protein from the soil metagenome is a novel enoyl-acyl carrier protein reductase: Structure-guided functional analysis. Kim SH; Khan R; Choi K; Lee SW; Rhee S FEBS J; 2020 Nov; 287(21):4710-4728. PubMed ID: 32112503 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and structural basis for Moraxella catarrhalis enoyl-acyl carrier protein reductase (FabI) inhibition by triclosan and estradiol. Katiki M; Neetu N; Pratap S; Kumar P Biochimie; 2022 Jul; 198():8-22. PubMed ID: 35276316 [TBL] [Abstract][Full Text] [Related]
16. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei. Lu H; Tonge PJ Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482 [TBL] [Abstract][Full Text] [Related]
17. Characterization of protein-ligand binding interactions of enoyl-ACP reductase (FabI) by native MS reveals allosteric effects of coenzymes and the inhibitor triclosan. Joyner PM; Tran DP; Zenaidee MA; Loo JA Protein Sci; 2022 Mar; 31(3):568-579. PubMed ID: 34882866 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan. Lee HH; Moon J; Suh SW Proteins; 2007 Nov; 69(3):691-4. PubMed ID: 17879346 [No Abstract] [Full Text] [Related]